Digital Pathology News

OptraSCAN was recently recognized by Frost and Sullivan with a Global Telepathology Enabling Technology Leadership Award. And why shouldn't they be recognized -- I think they are hitting on one of the key market segments that is largely...

“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise...

Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention.  In one of the pieces I mentioned...

A book review on our recent book "Digital Pathology: Historical Perspectives, Current Concepts & Future Applications" was written by Dr. Paul J van Diest, Professor of Pathology and Chairman, Department of Pathology, UMC Utrecht, The...

Potential new technology here that may limit number of breast biopsies previously deemed "unnecessary" using artificial intelligence to aid screening with mammography with tumor protein expression. Perhaps as many as 20% of breast biopsies...

Published August 29, 2016 By Simon Häger, Product Manager Sectra Digital Pathology Solution Although most pathology departments have not yet made the transition to digital, many are actively evaluating the business case. Why? Most...